The Merck Research Laboratories (MRL) Scientific Engagement and Emerging Discovery Science (SEEDS) program is an initiative seeking research collaborations with academic researchers to advance the most innovative discoveries for therapeutic targets, pathways and technologies. The MRL SEEDS program and subsequent collaborations underscore the importance of industry and academic interactions in the early discovery space.
The MRL SEEDS program was launched in 2020 with initial focus on Cardio/Renal/Metabolic/Ophthalmic diseases and platform technologies for the discovery and development of protein and antibody therapeutics.
As a first step in a potential collaboration, ideas for proposed projects should be submitted for evaluation by the Scientific Review Committee (SRC) comprised of scientists from Discovery Oncology (DO). Ideas are to be submitted in the form of a brief proposal form by May 21, 2023. Proposals will be evaluated by the MRL DO SEEDS Scientific Review Committee (SRC) and may be selected for awarding a 1-year research grant (up to $125,000 USD in direct costs plus institutional indirect costs). The 1-year grant can potentially be extended at the discretion of the MRL DO SEEDS SRC.
At the discretion of Merck, MRL scientists will work closely with investigators to make available relevant capabilities and technologies that will enhance the success of the joint research program. As part of the proposal and workplan development process, scientists from MRL will engage with lead investigators to ensure expertise and capabilities of both parties are incorporated into the project plan as applicable. During the grant period, the investigator and MRL scientists will meet at least quarterly for updates. A final report is required and it is expected that part or all of the results generated during the collaboration are disseminated in peer-reviewed publications.
For anyone interested in applying for MRL SEEDS Program, please contact Swapneeta Date, Ph.D., Assistant Director of Life Sciences Collaborations.
Program Highlights:
-
Award winning proposals will receive $125,000 research funding including institutional direct and indirect costs for 12 months
-
Potential opportunity to extend the grant
-
Awardees will have access to Merck R&D expertise and guidance
Eligibility & Application Instructions:
-
Principal investigators and Faculty (PI) employed by invited institutions are eligible to apply
-
Post-doctoral fellows and graduate students are not eligible to apply
-
An applicant can submit multiple pre-proposals
-
Past applicants are encouraged to reapply
-
Pre-proposals must provide objectives and work-plan achievable within 12 months
-
Pre-proposals must be submitted using the provided template
Contact CTTC contact listed above for pre-proposal template. Pre-proposals are due to CTTC on May 21st, 2023 at 9 PM Central.